This department is offering the University of Auckland grant to coordinate the Global Vaccine Data Network (GVDN) for safety monitoring of COVID-19 vaccines. The GVDN consists of 21 study sites across 13 countries, utilizing large-linked databases to assess the impact of biologics on populations. With expertise in vaccine safety studies and adverse event evaluation, the GVDN stands out for its geographic diversity and subject matter knowledge. The $7,000,000 grant aims to support the GVDN in its critical role in COVID-19 response efforts. Closing date for applications is April 16, 2021.
Opportunity ID: 332152
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-CK21-2107 |
| Funding Opportunity Title: | Globally coordinated safety monitoring for COVID-19 vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 7 |
| Posted Date: | Mar 16, 2021 |
| Last Updated Date: | Apr 13, 2021 |
| Original Closing Date for Applications: | Mar 26, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Apr 16, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | May 16, 2021 |
| Estimated Total Program Funding: | $5,665,726 |
| Award Ceiling: | $5,665,726 |
| Award Floor: | $75,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Auckland UniServices Limited |
Additional Information
| Agency Name: | Centers for Disease Control – NCEZID |
| Description: | The University of Auckland’s Auckland Univservices Limited is the coordinating site for the Global Vaccine Data Network (GVDN). The GVDN is an existing network of 21 study sites representing 13 countries (Argentina, Australia, Canada, China, Denmark, Finland, France, India, New Zealand, Taiwan, UK, US, and South Africa) across six continents. It is the largest known international big data collaboration using large-linked databases to examine the impact of biologics on populations. Each of the GVDN sites has experience in the conduct of vaccine safety studies using electronic databases, and most sites have prior vaccine safety evaluation experience using individual medical record review to evaluate possible cases of adverse events following immunization. There is no other existing organization that has the geographic diversity, population heterogeneity, breadth of subject matter expertise, and database robustness of the GVDN. These qualities will be especially important for the COVID-19 response. Coronavirus Aid, Relief, and Economic Security Act (CARES Act) funding in the amount $7,000,000. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Charles Denard
xyg9@cdc.gov Email:xyg9@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Corrected the CFDA number related to this NOFO. CFDA number changed from 93.344 to 93.318. | Apr 13, 2021 | |
| Corrected the CFDA number related to this NOFO. CFDA number changed from 93.344 to 93.318. | Mar 16, 2021 | |
| Corrected the CFDA number related to this NOFO. ACFDA number changed from 93.344 to 93.318. | Mar 16, 2021 | |
| Updated application due date, updated application package, and removed HHS Checklist. | Mar 16, 2021 | |
| Updated application due date, updated application package, and removed HHS Checklist. | Mar 16, 2021 | |
| Updated the announcement to extend the due date to April 16, 2021. | Mar 16, 2021 | |
| Mar 16, 2021 |
DISPLAYING: Synopsis 7
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-CK21-2107 |
| Funding Opportunity Title: | Globally coordinated safety monitoring for COVID-19 vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 7 |
| Posted Date: | Mar 16, 2021 |
| Last Updated Date: | Apr 13, 2021 |
| Original Closing Date for Applications: | Mar 26, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Apr 16, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | May 16, 2021 |
| Estimated Total Program Funding: | $5,665,726 |
| Award Ceiling: | $5,665,726 |
| Award Floor: | $75,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Auckland UniServices Limited |
Additional Information
| Agency Name: | Centers for Disease Control – NCEZID |
| Description: | The University of Auckland’s Auckland Univservices Limited is the coordinating site for the Global Vaccine Data Network (GVDN). The GVDN is an existing network of 21 study sites representing 13 countries (Argentina, Australia, Canada, China, Denmark, Finland, France, India, New Zealand, Taiwan, UK, US, and South Africa) across six continents. It is the largest known international big data collaboration using large-linked databases to examine the impact of biologics on populations. Each of the GVDN sites has experience in the conduct of vaccine safety studies using electronic databases, and most sites have prior vaccine safety evaluation experience using individual medical record review to evaluate possible cases of adverse events following immunization. There is no other existing organization that has the geographic diversity, population heterogeneity, breadth of subject matter expertise, and database robustness of the GVDN. These qualities will be especially important for the COVID-19 response. Coronavirus Aid, Relief, and Economic Security Act (CARES Act) funding in the amount $7,000,000. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Charles Denard
xyg9@cdc.gov Email:xyg9@cdc.gov |
DISPLAYING: Synopsis 6
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-CK21-2107 |
| Funding Opportunity Title: | Globally coordinated safety monitoring for COVID-19 vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 6 |
| Posted Date: | Mar 16, 2021 |
| Last Updated Date: | Apr 13, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Apr 16, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | May 16, 2021 |
| Estimated Total Program Funding: | $5,665,726 |
| Award Ceiling: | $5,665,726 |
| Award Floor: | $75,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Auckland UniServices Limited |
Additional Information
| Agency Name: | Centers for Disease Control – NCEZID |
| Description: | The University of Auckland’s Auckland Univservices Limited is the coordinating site for the Global Vaccine Data Network (GVDN). The GVDN is an existing network of 21 study sites representing 13 countries (Argentina, Australia, Canada, China, Denmark, Finland, France, India, New Zealand, Taiwan, UK, US, and South Africa) across six continents. It is the largest known international big data collaboration using large-linked databases to examine the impact of biologics on populations. Each of the GVDN sites has experience in the conduct of vaccine safety studies using electronic databases, and most sites have prior vaccine safety evaluation experience using individual medical record review to evaluate possible cases of adverse events following immunization. There is no other existing organization that has the geographic diversity, population heterogeneity, breadth of subject matter expertise, and database robustness of the GVDN. These qualities will be especially important for the COVID-19 response. Coronavirus Aid, Relief, and Economic Security Act (CARES Act) funding in the amount $7,000,000. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Charles Denard
xyg9@cdc.gov Email:xyg9@cdc.gov |
DISPLAYING: Synopsis 5
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-CK21-2107 |
| Funding Opportunity Title: | Globally coordinated safety monitoring for COVID-19 vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Mar 16, 2021 |
| Last Updated Date: | Apr 13, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Apr 16, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | May 16, 2021 |
| Estimated Total Program Funding: | $5,665,726 |
| Award Ceiling: | $5,665,726 |
| Award Floor: | $75,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Auckland UniServices Limited |
Additional Information
| Agency Name: | Centers for Disease Control – NCEZID |
| Description: | The University of Auckland’s Auckland Univservices Limited is the coordinating site for the Global Vaccine Data Network (GVDN). The GVDN is an existing network of 21 study sites representing 13 countries (Argentina, Australia, Canada, China, Denmark, Finland, France, India, New Zealand, Taiwan, UK, US, and South Africa) across six continents. It is the largest known international big data collaboration using large-linked databases to examine the impact of biologics on populations. Each of the GVDN sites has experience in the conduct of vaccine safety studies using electronic databases, and most sites have prior vaccine safety evaluation experience using individual medical record review to evaluate possible cases of adverse events following immunization. There is no other existing organization that has the geographic diversity, population heterogeneity, breadth of subject matter expertise, and database robustness of the GVDN. These qualities will be especially important for the COVID-19 response. Coronavirus Aid, Relief, and Economic Security Act (CARES Act) funding in the amount $7,000,000. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Charles Denard
xyg9@cdc.gov Email:xyg9@cdc.gov |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-CK21-2107 |
| Funding Opportunity Title: | Globally coordinated safety monitoring for COVID-19 vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.344 — Research, Monitoring and Outcomes Definitions for Vaccine Safety |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Mar 16, 2021 |
| Last Updated Date: | Mar 29, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Apr 16, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | May 16, 2021 |
| Estimated Total Program Funding: | $5,665,726 |
| Award Ceiling: | $5,665,726 |
| Award Floor: | $75,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Auckland UniServices Limited |
Additional Information
| Agency Name: | Centers for Disease Control – NCEZID |
| Description: | The University of Auckland’s Auckland Univservices Limited is the coordinating site for the Global Vaccine Data Network (GVDN). The GVDN is an existing network of 21 study sites representing 13 countries (Argentina, Australia, Canada, China, Denmark, Finland, France, India, New Zealand, Taiwan, UK, US, and South Africa) across six continents. It is the largest known international big data collaboration using large-linked databases to examine the impact of biologics on populations. Each of the GVDN sites has experience in the conduct of vaccine safety studies using electronic databases, and most sites have prior vaccine safety evaluation experience using individual medical record review to evaluate possible cases of adverse events following immunization. There is no other existing organization that has the geographic diversity, population heterogeneity, breadth of subject matter expertise, and database robustness of the GVDN. These qualities will be especially important for the COVID-19 response. Coronavirus Aid, Relief, and Economic Security Act (CARES Act) funding in the amount $7,000,000. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Charles Denard
xyg9@cdc.gov Email:xyg9@cdc.gov |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-CK21-2107 |
| Funding Opportunity Title: | Globally coordinated safety monitoring for COVID-19 vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.344 — Research, Monitoring and Outcomes Definitions for Vaccine Safety |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Mar 16, 2021 |
| Last Updated Date: | Mar 29, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Apr 16, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | May 16, 2021 |
| Estimated Total Program Funding: | $5,665,726 |
| Award Ceiling: | $5,665,726 |
| Award Floor: | $75,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Auckland UniServices Limited |
Additional Information
| Agency Name: | Centers for Disease Control – NCEZID |
| Description: | The University of Auckland’s Auckland Univservices Limited is the coordinating site for the Global Vaccine Data Network (GVDN). The GVDN is an existing network of 21 study sites representing 13 countries (Argentina, Australia, Canada, China, Denmark, Finland, France, India, New Zealand, Taiwan, UK, US, and South Africa) across six continents. It is the largest known international big data collaboration using large-linked databases to examine the impact of biologics on populations. Each of the GVDN sites has experience in the conduct of vaccine safety studies using electronic databases, and most sites have prior vaccine safety evaluation experience using individual medical record review to evaluate possible cases of adverse events following immunization. There is no other existing organization that has the geographic diversity, population heterogeneity, breadth of subject matter expertise, and database robustness of the GVDN. These qualities will be especially important for the COVID-19 response. Coronavirus Aid, Relief, and Economic Security Act (CARES Act) funding in the amount $7,000,000. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Charles Denard
xyg9@cdc.gov Email:xyg9@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-CK21-2107 |
| Funding Opportunity Title: | Globally coordinated safety monitoring for COVID-19 vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.344 — Research, Monitoring and Outcomes Definitions for Vaccine Safety |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 16, 2021 |
| Last Updated Date: | Mar 29, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Apr 16, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | May 16, 2021 |
| Estimated Total Program Funding: | $5,665,726 |
| Award Ceiling: | $5,665,726 |
| Award Floor: | $75,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Auckland UniServices Limited |
Additional Information
| Agency Name: | Centers for Disease Control – NCEZID |
| Description: | The University of Auckland’s Auckland Univservices Limited is the coordinating site for the Global Vaccine Data Network (GVDN). The GVDN is an existing network of 21 study sites representing 13 countries (Argentina, Australia, Canada, China, Denmark, Finland, France, India, New Zealand, Taiwan, UK, US, and South Africa) across six continents. It is the largest known international big data collaboration using large-linked databases to examine the impact of biologics on populations. Each of the GVDN sites has experience in the conduct of vaccine safety studies using electronic databases, and most sites have prior vaccine safety evaluation experience using individual medical record review to evaluate possible cases of adverse events following immunization. There is no other existing organization that has the geographic diversity, population heterogeneity, breadth of subject matter expertise, and database robustness of the GVDN. These qualities will be especially important for the COVID-19 response. Coronavirus Aid, Relief, and Economic Security Act (CARES Act) funding in the amount $7,000,000. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Charles Denard
xyg9@cdc.gov Email:xyg9@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-CK21-2107 |
| Funding Opportunity Title: | Globally coordinated safety monitoring for COVID-19 vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.344 — Research, Monitoring and Outcomes Definitions for Vaccine Safety |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 16, 2021 |
| Last Updated Date: | Mar 16, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 26, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | May 19, 2021 |
| Estimated Total Program Funding: | $5,665,726 |
| Award Ceiling: | $5,665,726 |
| Award Floor: | $75,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Auckland UniServices Limited |
Additional Information
| Agency Name: | Centers for Disease Control – NCEZID |
| Description: | The University of Auckland’s Auckland Univservices Limited is the coordinating site for the Global Vaccine Data Network (GVDN). The GVDN is an existing network of 21 study sites representing 13 countries (Argentina, Australia, Canada, China, Denmark, Finland, France, India, New Zealand, Taiwan, UK, US, and South Africa) across six continents. It is the largest known international big data collaboration using large-linked databases to examine the impact of biologics on populations. Each of the GVDN sites has experience in the conduct of vaccine safety studies using electronic databases, and most sites have prior vaccine safety evaluation experience using individual medical record review to evaluate possible cases of adverse events following immunization. There is no other existing organization that has the geographic diversity, population heterogeneity, breadth of subject matter expertise, and database robustness of the GVDN. These qualities will be especially important for the COVID-19 response. Coronavirus Aid, Relief, and Economic Security Act (CARES Act) funding in the amount $7,000,000. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Charles Denard
xyg9@cdc.gov Email:xyg9@cdc.gov |
Related Documents
Folder 332152 Full Announcement-Full Announcement -> CDC-RFA-CK21-2107.pdf
Folder 332152 Full Announcement-Full Announcement -> CDC-RFA-CK21-2107 rev1.pdf
Packages
| Agency Contact Information: | Charles Denard xyg9@cdc.gov Email: xyg9@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.318 | NCEZID | Globally coordinated safety monitoring for COVID-19 vaccines | PKG00266510 | Mar 16, 2021 | Apr 16, 2021 | View |
Package 1
Mandatory forms
332152 SF424_3_0-3.0.pdf
332152 Project_AbstractSummary_2_0-2.0.pdf
332152 SFLLL_2_0-2.0.pdf
332152 SF424A-1.0.pdf
332152 BudgetNarrativeAttachments_1_2-1.2.pdf
332152 ProjectNarrativeAttachments_1_2-1.2.pdf
332152 Key_Contacts_2_0-2.0.pdf
Optional forms
332152 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
